Related references
Note: Only part of the references are listed.Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants
Jennifer E. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults
Katherine Williams et al.
VACCINE (2022)
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Relative Effectiveness of Cell-based Versus Egg-based Quadrivalent Influenza Vaccines in Children and Adolescents in the United States During the 2019-2020 Influenza Season
Mahrukh Imran et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)
Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial
Brandon J. Essink et al.
PEDIATRICS (2022)
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study
Carla S. Walti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Baseline CD3+CD56+(NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy
Evelin A. Leibinger et al.
FRONTIERS IN IMMUNOLOGY (2021)
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
Curtis R. Chong et al.
CLINICAL INFECTIOUS DISEASES (2020)
Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant
Anne L. Ryan et al.
BONE MARROW TRANSPLANTATION (2020)
Immunogenicity of the inactivated influenza vaccine in children who have undergone autologous stem cell transplant
Anne L. Ryan et al.
BONE MARROW TRANSPLANTATION (2020)
Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized study
Timo Vesikari et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children
Krissy K. Moehling et al.
VACCINE (2020)
Vaccine-preventable disease following allogeneic haematopoietic stem cell transplant in Western Australia
Anne L. Ryan et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2019)
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Malgorzata Mikulska et al.
LANCET INFECTIOUS DISEASES (2019)
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Catherine Cordonnier et al.
LANCET INFECTIOUS DISEASES (2019)
The human antibody response to influenza A virus infection and vaccination
Florian Krammer
NATURE REVIEWS IMMUNOLOGY (2019)
A multiyear quality improvement project to increase influenza vaccination in a pediatric oncology population undergoing active therapy
Randal S. Olshefski et al.
PEDIATRIC BLOOD & CANCER (2018)
Immune response to influenza vaccination in children with cancer
Dimitrios Doganis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Immunology and efficacy of MF59-adjuvanted vaccines
Eun-Ju Ko et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
Heinz Laeubli et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Vaccines in pediatric transplant recipients-Past, present, and future
Daniel E. Dulek et al.
PEDIATRIC TRANSPLANTATION (2018)
Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events
Dirk H. Wijn et al.
EUROPEAN JOURNAL OF CANCER (2018)
The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia
April Sykes et al.
JOURNAL OF PEDIATRICS (2017)
Vaccination against influenza at a European pediatric cancer center: immunization rates and attitudes among staff, patients, and their families
Aleksandra Pettke et al.
SUPPORTIVE CARE IN CANCER (2017)
A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients
Y. Natori et al.
BONE MARROW TRANSPLANTATION (2017)
Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
Rishi S. Kotecha et al.
CANCER MEDICINE (2016)
Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer
Daniel K. Choi et al.
PEDIATRIC BLOOD & CANCER (2016)
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection
Hana Hakim et al.
VACCINE (2016)
Quality Improvement Initiative to Increase Influenza Vaccination in Pediatric Cancer Patients
Jason L. Freedman et al.
PEDIATRICS (2015)
The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab
Ake Berglund et al.
ACTA ONCOLOGICA (2014)
Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature
Matthew Biggerstaff et al.
BMC INFECTIOUS DISEASES (2014)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial
Terry Nolan et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Safety of High Dose Trivalent Inactivated Influenza Vaccine in Pediatric Patients with Acute Lymphoblastic Leukemia
Meghann McManus et al.
PEDIATRIC BLOOD & CANCER (2014)
Immunogenicity of a 2009 Pandemic Influenza Virus A H1N1 Vaccine, Administered Simultaneously With the Seasonal Influenza Vaccine, in Children Receiving Chemotherapy
Gabor Ottoffy et al.
PEDIATRIC BLOOD & CANCER (2014)
Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age
David P. Greenberg et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
Nathalie Dhedin et al.
VACCINE (2014)
A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation
Nicole A. Karras et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Lack of Association of Guillain-Barre Syndrome With Vaccinations
Roger Baxter et al.
CLINICAL INFECTIOUS DISEASES (2013)
A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort
Leslie S. Kersun et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Does vaccine dose predict response to the monovalent pandemic H1N1 influenza a vaccine in children with acute lymphoblastic leukemia? A single-centre study
T. Ronan Leahy et al.
PEDIATRIC BLOOD & CANCER (2013)
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non- Hodgkin lymphoma patients previously treated with rituximab containing regimens
Davide Bedognetti et al.
BLOOD (2012)
Cellular and humoral immunity elicited by influenza vaccines in pediatric hematopoietic-stem cell transplantation
Valerie Guerin-El Khourouj et al.
HUMAN IMMUNOLOGY (2012)
Successful H1N1 Influenza Vaccination of Children Receiving Chemotherapy for Solid Tumors
Kayss Shahin et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
Clinical and Demographic Characteristics of Seasonal Influenza in Pediatric Patients With Cancer
Silvana B. Carr et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults
Hana Hakim et al.
VACCINE (2012)
Influenza viruses and cross-reactivity in healthy adults: Humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus
Anna M. Iorio et al.
VACCINE (2012)
SAFE ADMINISTRATION OF SEASONAL INFLUENZA VACCINE TO CHILDREN WITH EGG ALLERGY OF ALL SEVERITIES
Laura E. Howe et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2011)
Enhanced Immune Response after a Second Dose of an AS03-Adjuvanted H1N1 Influenza A Vaccine in Patients after Hematopoietic Stem Cell Transplantation
Saskia Gueller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
Olav Erich Yri et al.
BLOOD (2011)
Pandemic (H1N1) 2009 vaccine in paediatric oncology patients: one dose or two doses?
Frankie W. T. Cheng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
Bilal Mohty et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin's Lymphoma Patients Treated with Rituximab-Containing Regimens
Davide Bedognetti et al.
JOURNAL OF IMMUNOLOGY (2011)
Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer
Silvana Carr et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Immune Response to 2009 Pandemic H1N1 Influenza Virus A Monovalent Vaccine in Children With Cancer
Ting-Yu Yen et al.
PEDIATRIC BLOOD & CANCER (2011)
The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic
Dan Engelhard et al.
VACCINE (2011)
Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus
Susanna Esposito et al.
VIROLOGY JOURNAL (2011)
Serological response to influenza vaccine after hematopoetic stem cell transplantation
S. Songuel Yalcin et al.
ANNALS OF HEMATOLOGY (2010)
Patient and family education in HSCT: improving awareness of respiratory virus infection and influenza vaccination. A descriptive study and brief intervention
P. E. Ferguson et al.
BONE MARROW TRANSPLANTATION (2010)
Immunogenicity of Pandemic (H1N1) 2009 Vaccine in Children with Cancer in the United Kingdom
Jessica Bate et al.
CLINICAL INFECTIOUS DISEASES (2010)
The Efficacy of Influenza Vaccination in a Pediatric Oncology Population
Anne Reilly et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
CURRENT CONCEPTS Influenza Vaccines for the Future
Linda C. Lambert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunogenicity of Trivalent Influenza Vaccine in Children With Acute Lymphoblastic Leukemia During Maintenance Therapy
Elham Shahgholi et al.
PEDIATRIC BLOOD & CANCER (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells
Maria Mamani-Matsuda et al.
BLOOD (2008)
Influenza-associated morbidity in children with cancer
Sarah K. Tasian et al.
PEDIATRIC BLOOD & CANCER (2008)
Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation
Gayane Avetisyan et al.
TRANSPLANTATION (2008)
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age
Stan L. Block et al.
VACCINE (2008)
Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors
Omer Bektas et al.
PEDIATRIC BLOOD & CANCER (2007)
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: A double-blind, controlled trial in adult patients with non-hodgkin B cell lymphoma
Amar Safdar et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immune response after influenza vaccination in children with cancer
A Matsuzaki et al.
PEDIATRIC BLOOD & CANCER (2005)
The benefit of influenza vaccination after bone marrow transplantation
CM Machado et al.
BONE MARROW TRANSPLANTATION (2005)
Influenza immunisation in children with solid tumours
J Chisholm et al.
EUROPEAN JOURNAL OF CANCER (2005)
Epidemiology and outcomes of serious influenza-related infections in the cancer population
CD Cooksley et al.
CANCER (2005)
Antigen-specific memory B cell development
LJ McHeyzer-Williams et al.
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia
CC Porter et al.
PEDIATRIC BLOOD & CANCER (2004)
Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation
WN Haining et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Dendritic-cell control of pathogen-driven T-cell polarization
ML Kapsenberg
NATURE REVIEWS IMMUNOLOGY (2003)
Extrafollicular antibody responses
ICM MacLennan et al.
IMMUNOLOGICAL REVIEWS (2003)
Influenza immunization practices among pediatric oncologists
CC Porter et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients
RK Ramanathan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
P Ljungman et al.
BONE MARROW TRANSPLANTATION (2001)
Response to influenza immunisation during treatment for cancer
JC Chisholm et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients
K Pauksen et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
